10-K: PureCycle Technologies Reports 2025 Results, Advances Global Expansion

PureCycle Technologies, Inc. reported its 2025 annual results, highlighting initial revenues, significant capital raises, and progress on global expansion plans despite operational challenges at its Ironton facility and a substantial net loss.

Summary

• PureCycle Technologies, Inc. (PCT) is commercializing a patented dissolution recycling technology for polypropylene, restoring waste into like-new PureFive® resin.
• Reported approximately $8.4 million in revenues for the year ended December 31, 2025, compared to no revenues in 2024.
• Experienced an operating loss of $181.4 million in 2025, an increase from $145.4 million in 2024.
• Net loss for 2025 was $182.6 million, an improvement from $289.1 million in 2024, primarily due to changes in fair value of warrants.
• Successfully raised significant capital in 2025, including $33.0 million from common stock private placement, $36.9 million from Series A Bonds sales, and $300.0 million from Series B Convertible Perpetual Preferred Stock.
• The Ironton Facility achieved mechanical completion in 2023 and commenced pellet production but is not yet operating at full capacity due to intermittent mechanical challenges.
• Plans for global expansion include a 130 million pound per year facility in Thailand (operational late 2027), a 130 million pound per year facility in Belgium (operational mid to late 2028), and a redesigned 300 million pound per year facility in Augusta, Georgia (operational by 2030).
• Received additional FDA Letters of No Objection (LNOs) for PureFive® resin in food-contact applications, allowing use for all food types under various conditions.
• Recognized a $15.1 million write-down of long-lead equipment in 2025 due to redesign plans for the Augusta Facility and re-purposing equipment.
• Total consolidated indebtedness as of December 31, 2025, was $363.7 million.
• Cash and cash equivalents were $156.7 million as of December 31, 2025, up from $15.7 million in 2024.
• The company's going concern doubt has been alleviated for at least the next twelve months due to the Series B Preferred Stock funding.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mixed filing. While the company achieved initial revenues and secured significant funding to alleviate immediate going concern doubts, persistent operational challenges at its flagship facility, increasing losses, and substantial equipment write-downs indicate ongoing execution risks and a long path to sustained profitability.

Positives

• Generated $8.355 million in revenues in 2025, a significant increase from $0 in 2024, indicating initial commercialization.
• Successfully raised substantial capital in 2025: $33.0 million from common stock, $36.9 million from Series A Bonds, and $300.0 million from Series B Convertible Perpetual Preferred Stock.
• Alleviated previously disclosed substantial doubt about the company's ability to continue as a going concern for the next twelve months.
• Received additional FDA Letters of No Objection (LNOs) for PureFive® resin, expanding its use in all food types under various conditions, enhancing market potential.
• Progressed on global expansion plans with facilities in Thailand (expected late 2027), Belgium (expected mid to late 2028), and a redesigned Augusta facility (expected by 2030).
• Secured a €40 million grant from the European Union Innovation Fund for the Belgium Facility construction costs, expected in H1 2026.
• Amended P&G license to permanently waive clawback exclusivity for North American plants and extended deadlines for other regions.
• Research and Development Lab in Durham, North Carolina, opened in 2024, focusing on advanced analytical techniques and energy reduction.

Negatives

• Reported a net loss of $182.6 million in 2025, although an improvement from $289.1 million in 2024.
• Operating loss increased to $181.4 million in 2025 from $145.4 million in 2024.
• The Ironton Facility is not yet operating at its expected full capacity due to intermittent mechanical challenges, including issues with removing other plastics/additives and sustaining continuous operations.
• Recognized a $15.1 million write-down of long-lead equipment in 2025 due to redesign plans for the Augusta Facility, with potential for additional write-downs.
• Cost of operations increased by $23.6 million in 2025, driven by higher production-related costs, a $3.7 million loss on disposal of fixed assets, and $3.1 million higher facilities costs.
• Selling, general, and administrative expenses increased by $6.3 million, partly due to $9.0 million in professional services for future facility planning and $3.5 million in employee-related expenses.
• Incurred a $4.4 million loss on extinguishment of debt in 2025 related to paying off equipment financing.
• Accrued an additional $12.2 million for the Denham-Blythe arbitration panel decision, including $4.5 million for prejudgment interest.
• The company is dependent on raising capital to fund operations and future growth, with future expansion reliant on additional capital raises and/or project financing.
• Stock price performance significantly underperformed the Russell 2000 and S&P Small Cap 600 Materials indices from March 2021 to December 2025.

Risks

• Inability to obtain funding for operations, future capital requirements, and future growth, and to continue as a going concern.
• Inability to meet regulatory requirements for PureFive® resin in food-grade applications and broader facility operations.
• Uncertainty regarding future financial performance, including business plans, expansion, revenues, pricing, operating expenses, liquidity, and capital expenditures.
• Failure of the Ironton Facility to achieve appropriate certification and commence full-scale commercial operations in a timely and cost-effective manner.
• Inability to meet requirements imposed by funding for operations, including Ironton and Planned Facilities.
• Hazards and operational risks at manufacturing facilities leading to injury, business disruption, liability, and increased costs.
• Inability to complete funding and construction of the Thailand, Belgium, and Augusta Facilities in a timely and cost-effective manner.
• Inability to procure, sort, and process polypropylene plastic waste at planned Feed PreP facilities.
• Failure to maintain exclusivity under The Procter & Gamble Company (P&G) license.
• Failure of business model and growth strategy implementation, including achieving one billion pounds of installed polypropylene recycling capability by 2030.
• Inability to negotiate multi-year offtake agreements at appropriate margins.
• Adverse effects from economic, business, and competitive factors, including interest rates, capital availability, economic cycles, and tariffs.
• Changes in prices and availability of materials (e.g., steel), including those caused by inflation, tariffs, and supply chain conditions.
• Inability to source feedstock with a high polypropylene content at a reasonable cost.
• Development of direct competitors in the recycled polypropylene segment impacting demand.
• Outcome of any legal or regulatory proceedings.
• Geopolitical risk and changes in applicable laws or regulations.
• Changes in prices and availability of labor, employee turnover, and increased employee-related costs.
• Business disruptions due to political or economic instability, pandemics, or armed hostilities.
• Operational risks associated with operating facilities at nameplate capacity.
• Inability to achieve or sustain profitability as a low-revenue early commercial-stage company.
• Termination or conversion of the P&G license if construction and sales deadlines for non-North American facilities are missed.
• Substantial indebtedness, restrictive covenants, and potential inability to obtain additional financing.
• Risks and uncertainties related to litigation, regulatory actions, and investigations.
• Inability to consistently execute capital investment projects to cost, schedule, and operability targets.
• Delays in commissioning and obtaining independent engineer certification of operational performance at Ironton or new projects.
• Reliance on a single facility (Ironton) for all operations and lack of business diversification.
• Cybersecurity incidents and failure to maintain system integrity.
• Inability to sufficiently protect proprietary rights and disputes over intellectual property.
• Climate change or related legal/regulatory measures affecting financial condition and operations.
• Negative impact from volatility in the political and economic environment, including inflation and interest rates.
• Uncertainty of technology scalability to commercial-scale profitability, especially regarding consistent quality (odor).
• Failure to consummate strategic endeavors for PureFive® resin sales.
• Failure to secure sufficient quantities of waste polypropylene feedstock.
• Changes to international trade agreements, tariffs, import/excise duties, taxes affecting global expansion.
• Feed PreP facilities not being viable or achieving expected efficiencies.
• Feedstock+ pricing model not being successful or counterparties reducing fixed base price.
• Hazards and operational risks at manufacturing facilities (chemicals, fires, explosions, equipment damage).
• Market for PureFive® resin still in development, and acceptance by manufacturers/customers not guaranteed.
• Premium pricing in offtake agreements adversely affecting new customer acquisition.
• Fluctuations in index prices for certain offtake agreements impacting financial results if virgin resin prices are materially lower than PureFive® production costs.
• Competition reducing demand or negatively affecting sales mix/price realization.
• P&G sublicensing intellectual property under the Grant-Back increasing market supply.
• Delays to direct customer commercial sales impacting financial results.
• Inability to meet applicable regulatory requirements for food-grade applications in various regions.
• Legislative, regulatory or judicial developments could affect business.
• Dependence on management and key personnel, and inability to attract/retain highly skilled employees.
• Future sales of common stock by existing stockholders depressing stock price.
• Future offerings of debt or equity securities diluting existing stockholders.
• Conversion of Green Convertible Notes and Convertible Preferred Shares diluting ownership.

Future Outlook

PureCycle Technologies anticipates continued revenue growth from customer application trials and the commercialization of its PureFive® resin. The company plans significant global expansion with new facilities in Thailand (late 2027), Belgium (mid to late 2028), and Augusta, Georgia (by 2030), aiming for one billion pounds of installed polypropylene recycling capability by 2030. Future expansion and long-term going concern are dependent on improved Ironton Facility operations, successful commercialization, and financing for planned facilities.

Management Comments

• Our current financial projections support our ability to meet our funding obligations as they become due for at least the twelve-month period from the date that these financial statements were issued.
• Management continues to evaluate different strategies and may pursue additional actions to further increase our liquidity position.
• The Series B Convertible Perpetual Preferred Stock funding has led management to conclude that the previously disclosed substantial doubt about the Company's ability to continue as a going concern for a twelve-month period following the date that these financial statements were available to be issued is no longer present.
• The Company's current financial projections support the Company's ability to meet its obligations as they become due for at least one year from the issuance of these financial statements.
• The Company's ability to continue as a going concern longer term is dependent on continued improvement in operations at the Company's first commercial-scale recycling facility in Lawrence County, Ohio (the 'Ironton Facility'), the commercialization of its PureFive® resin product, and the successful construction and sale of product from its future Augusta, Thailand and Belgium Facilities.
• We believe that the current shifting market expectations toward sustainable sourcing of consumer plastics, and certain regulatory developments in support of plastic recycling, provide some protection from the price risk related to fluctuating commodity prices.
• We believe our Feedstock+ pricing model provides certain protection from the risk of increased prices in obtaining and processing raw materials utilized in our Purification process.

Industry Context

StockSavvy.ai notes that PureCycle Technologies operates within the rapidly evolving plastic recycling industry, driven by increasing consumer demand, corporate sustainability goals, and federal/state regulations for sustainable products. The company's patented dissolution technology offers a solution for high-quality, food-safe recycled polypropylene, addressing a critical gap where traditional mechanical and chemical recycling methods fall short. The global expansion plans align with the broader industry trend of scaling up recycling infrastructure to combat the vast majority of polypropylene products currently not being recycled. The receipt of FDA LNOs positions PureCycle favorably in the food packaging sector, a high-value market for recycled plastics.

Comparison to Industry Standards

• PureFive® resin performed comparably to virgin polypropylene in common food and beverage industry benchmarks for melt flow, mechanical properties, purity, odor, and function (lift decay, hinge break, impact resistance).
• The dissolution process is expected to utilize significantly less energy and reduce production costs compared to the production of virgin polypropylene resin.
• The technology offers a substantially improved odor profile compared to traditional mechanically-recycled polypropylene.
• The company aims to bring one billion pounds of installed polypropylene recycling capability online by 2030, a significant scale-up in the nascent high-quality recycled PP market.

Management Changes

Corporate Governance

Legal Proceedings

• Denham-Blythe Arbitration: AAA arbitration panel awarded Denham-Blythe approximately $15.0 million plus interest and attorney's fees. The company disagrees with the findings and conclusions and is evaluating whether to appeal the final award. An additional $12.2 million was accrued in 2025, bringing the total accrued for the DB contract to $23.1 million as of December 31, 2025.
• Winter Garden Lease Dispute: The company filed a complaint for declaratory relief against Crown Industrial Partners, LLC, alleging breach of lease for failing to repair, replace, and restore utility and sewer lines and hindering performance. Crown filed an Answer and Counterclaim, seeking damages for the company's alleged breach. Discovery is ongoing, and the outcome is currently not estimable.

Related Party Transactions

• Purchased $0.8 million of certain chemicals from Milliken & Company in 2025.
• Has a $200.0 million revolving credit facility with Sylebra Capital Management (a greater than 5% beneficial owner). Borrowed and repaid $10.0 million in May/June 2025. Paid $0.5 million in commitment fees in both 2025 and 2024.
• Executed a 30-day promissory note with Pure Plastic for $4.9 million in June 2025, which was repaid with $0.02 million in accrued interest.
• Sold $22.8 million in aggregate par amount of Series A Bonds owned by PCT LLC to related parties for gross proceeds of $20.1 million in 2025.
• Investment entities affiliated with Pure Crown, Sylebra, Daniel Gibson, and Samlyn participated in the $300.0 million Series B Convertible Perpetual Preferred Stock private placement in June 2025.
• Issued 4,003 shares of its Series A Preferred Stock for in-kind payment of dividends in September 2025, with 2,001 shares issued to Sylebra and 2,002 shares to Samlyn.
• Glockner, a related party, exercised 0.1 million of their outstanding Series A Warrants on July 28, 2025, for $1.2 million in cash.
• Affiliates of a greater than 5% beneficial owner purchased $50.0 million aggregate principal amount of the Green Convertible Notes in August 2023.
• Pure Plastic (affiliates are greater than 5% beneficial owners) purchased approximately $94.3 million in aggregate par amount of Bonds owned by PCT LLC in May 2024.
• Affiliates of Sylebra and Samlyn (related parties) participated in the Series A Preferred Stock, Common Stock, and Series C Warrants private placement in September 2024.

Stakeholder Impact

• Shareholders: Face dilution risk from future equity offerings and conversion of Green Convertible Notes and Series B Convertible Perpetual Preferred Stock. Potential stock price volatility from existing stockholders selling shares after lock-up expiration.
• Employees: Equity-based compensation plans are in place. The company's success is dependent on retaining key personnel and attracting skilled labor. The Chief Financial Officer, Jaime Vasquez, is retiring.
• Customers: Potential for high-quality, food-safe recycled polypropylene (PureFive® resin) to meet sustainability goals. Risk of delays in customer acceptance and supply chain disruptions from operational issues at facilities.
• Suppliers: Dependence on reliable and cost-effective sourcing of polypropylene waste feedstock. Risk of price fluctuations and supply shortages.
• Creditors: Substantial indebtedness ($363.7 million) and restrictive covenants. The alleviation of going concern doubt for the short term is positive, but long-term ability to service debt depends on operational improvements and successful commercialization.

Next Steps

• Improve performance at various steps in the Ironton Purification process, potentially including equipment changes.
• Conduct additional testing and make further FDA LNO submissions for additional post-consumer recycled feedstock sources and expanded COUs.
• Negotiate and execute the €40 million EU Innovation Fund grant agreement in the first half of 2026.
• Submit the permit application for the Belgium Facility with relevant authorities in 2026.
• Continue designing the larger Purification facility for Augusta, incorporating learnings from Ironton.
• Begin construction of the Augusta Facility no later than March 2028.
• Bring a total of one billion pounds of installed polypropylene recycling capability online by 2030.
• Monitor and protect intellectual property rights and potentially litigate against infringement.
• Identify, hire, develop, motivate, and retain highly qualified personnel.
• Evaluate the impact of new accounting standards (ASU 2025-12, 2025-11, 2025-10, 2025-06, 2024-04, 2024-03, 2025-01).
• Potentially appeal the Denham-Blythe arbitration panel decision.
• Resolve the Winter Garden Lease Dispute.
• Redeem Series A Preferred Stock if sufficient proceeds from Series A Warrants exercise are received by March 17, 2026, and the Board approves.
• Public and Private Warrants expiration date extended to June 17, 2026.
• Series A Warrants expiration date extended to March 17, 2027, with reduced redemption price.

Key Dates

Recommendation

PureCycle Technologies presents a high-risk, high-reward profile. While the company has made strides in commercializing its innovative recycling technology, securing significant funding, and expanding globally, it continues to face substantial operational challenges at its flagship facility, leading to increased operating losses and equipment write-downs. The alleviation of immediate going concern doubts is positive, but long-term profitability remains uncertain and dependent on successful execution of complex expansion plans and consistent product quality. Given the early commercial stage, significant capital requirements, and ongoing operational hurdles, a 'hold' recommendation is appropriate for investors with a high-risk tolerance who are willing to monitor progress closely, as the long-term potential is significant if execution improves.

Keywords

PureCycle Technologies, PCT, polypropylene recycling, PureFive resin, dissolution technology, SEC filing, 10-K, sustainability, circular economy, plastic waste, Ironton Facility, Augusta Facility, Thailand Facility, Belgium Facility, capital raise, FDA LNO, corporate governance, financial performance, risk factors, environmental regulation, intellectual property, stock performance